• The Company
    • Who we are
    • Partner Portal
  • Meet the Partners
  • Our Approach
  • Portfolio
    • Current Portfolio
    • Historic Portfolio
  • News
  • Contact Us
The Vertical Group
Investing for Innovation

Women of Healthtech: These 4 CEOs want to change future of health care

5/31/2018

 
Via: Silicon Valley Business Journal 
All are natural leaders, and they share the same gender and title. But each has taken a different path to Silicon Valley success in the growing healthtech sector, with its own twists and trials.

Their stories, however, in an era marked by angst in executive suites and VC conference rooms over gender equity and harassment-related issues, reveal patterns in a larger tapestry. And perhaps glimpses of a few paths to progress.

Leslie Trigg, CEO of 110-employee Outset Medical in San Jose— which has raised $190 million and won FDA clearance for a revolutionary new dialysis treatment platform — credits three male mentors for helping her on the path that led to those accomplishments.

But before that, she took her new MBA from UC Berkeley’s Haas School of Business and applied to virtually every biotechnology company around.

“I got rejected by every biotech company,” Trigg says, “because I was essentially competing against people who had an MBA but (also) had an undergraduate science degree,” which she didn’t have.

Read More: 
https://www.bizjournals.com/sanjose/news/2018/05/31/women-of-healthtech-these-4-ceos-want-to-change.html?b=1527776492%5E21269447

Omada Health Achieves Full CDC Recognition

5/30/2018

 
Via: Omada Health
Digital Therapeutics Pioneer Becomes Largest Diabetes Prevention Program Provider to Achieve Milestone

San Francisco, CA (May 30, 2018) -- Omada Health today announced that the company has graduated to full recognition status from the Centers for Disease Control and Prevention (CDC). Omada now becomes the largest Diabetes Prevention Program (DPP) provider, in-person or virtual, to achieve full recognition from the CDC.

“Today’s accomplishment is the culmination of work with the team at CDC that began back in 2011,” said Omada Co-Founder and CEO Sean Duffy. “Full recognition is a validation of our proprietary curriculum, our ability to engage and retain participants, and above all, the outcomes we achieve with individuals at risk for type 2 diabetes. As we continue to build integrated partnerships with health plans and employers, customers can be sure that their members are receiving a scalable, adaptable, best-in-class DPP solution.”

Read More: ​https://www.omadahealth.com/press/press-release-omada-health-achieves-full-cdc-approval

New Clinical Study: Hinge Health Improves Chronic Knee Pain 61% and Decreases Surgery 63% with Wearable Sensors and Behavioral Coaching

5/22/2018

 
Via: Cision PRWeb
New study shows Hinge Health wearable sensors and coaching significantly improves chronic knee pain without opioids or surgery

Hinge Health, based in Silicon Valley, is the first digital health company to demonstrate that a mobile-first, at-home exercise therapy and behavioral coaching solution improves outcomes for chronic knee pain by 61% and elective surgeries by 63%. Founded in 2014 by clinical researchers, Hinge Health is a rare digital health company to choose the higher hurdle of demonstrating statistically significant outcomes in a pre-registered randomized control trial (N=162).

In an analysis of participants that completed the clinical trial intervention, published April 2018 in the Journal of Medical Internet Research, the Hinge Health treatment group achieved 61% improvement in Visual Analog Scale (VAS) pain from baseline compared to 21% improvement by the control group (P<0.001). Likelihood of surgery decreased in the Hinge Health treatment group from 63% compared to 17% in the control group. A cost-benefit analysis estimates that the study’s employer saved $438,000 in avoided surgeries across the 101 participants in the Hinge Health treatment group. Participants who completed the program averaged 3.3 exercise therapy sessions per week and engagement each week averaged 80%.

Read More: 
https://www.prweb.com/releases/2018/05/prweb15506621.htm

OncoMed Pharmaceuticals: Assessing The Prospect Of A Potential Robust Winner

5/21/2018

 
Via: Seeking Alpha
Summary:

- As a promising grower, OncoMed is leveraging on the “more shots on goal” strategy. Despite earlier missed clinical outcomes, the company is brewing stellar molecules that are approaching their binaries.
- Anti-TIGIT is an interesting franchise being investigated in combination with an anti-PD1. We’re most interested in navicixizumab, a multi-dimensional molecule being assessed in combination with the standard chemotherapy.
- If the later-stage clinical outcomes are favorable as we prognosticated, the company can become a target for acquisition.

Read More: ​https://seekingalpha.com/article/4175755-oncomed-pharmaceuticals-assessing-prospect-potential-robust-winner

    Archives

    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    April 2015
    March 2015
    February 2015
    January 2015
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    February 2014
    January 2014
    December 2013
    October 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013

    RSS Feed

© The Vertical Group - info@vertical-group.com
 106 Allen Road, Suite 207, Basking Ridge, NJ 07901 | (908) 277-3737
160 Bovet Road, Suite 400, San Mateo, CA  94402 | (650) 566-9060
Picture
Website by Custom Computing Labs